No profile data available.
Neumora Therapeutics, Inc. (NMRA) is a healthcare company in the brain and nerve treatment drugs industry, based in Watertown, United States, with about 63 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$236.93 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $89.38 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.
Neumora Therapeutics reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$89.38 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Tonix Pharmaceuticals Holding Corp. (TNXP), NRx Pharmaceuticals, Inc. (NRXP), Coya Therapeutics, Inc. (COYA), ProMIS Neurosciences, Inc. (PMN).